Threshold Pharma (NASDAQ: THLD) disclosed the following in a U.S. SEC filing on Tuesday: Item 8.01. Other InformationAs previously reported ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE